Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Acq. announced
Appointed COO
Quarterly results
Director departure
Appointed director
CC transcript
SYNAGEVA BIOPHARMA CORP (GEVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/23/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
06/23/2015 4 BAKER FELIX (Former 10% owner and Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 Quinn Anthony (EVP, CMO, & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 DAVIS STEPHEN (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 3,000 options to buy @ $10.1, valued at $30.3k
Disposed/sold 3,000 options to buy @ $11.35, valued at $34.1k
Disposed/sold 3,000 options to buy @ $20.6, valued at $61.8k
Disposed/sold 15,000 options to buy @ $23, valued at $345k
Disposed/sold 4,000 options to buy @ $23.95, valued at $95.8k
Disposed/sold 3,000 options to buy @ $25, valued at $75k
Disposed/sold 7,500 options to buy @ $40.32, valued at $302.4k
Disposed/sold 7,500 options to buy @ $40.74, valued at $305.6k
Disposed/sold 7,500 options to buy @ $80.35, valued at $602.6k
06/23/2015 4 Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 286 shares @ $0
Disposed/sold 1,031 shares @ $0
Disposed/sold 72,000 shares @ $0
Disposed/sold 22,512 options to buy @ $1.7, valued at $38.3k
Disposed/sold 136,052 options to buy @ $23, valued at $3.1M
Disposed/sold 128,000 options to buy @ $40.32, valued at $5.2M
Disposed/sold 148,000 options to buy @ $40.74, valued at $6M
Disposed/sold 120,000 options to buy @ $80.35, valued at $9.6M
06/23/2015 4 Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 1,375 options to buy @ $10.1, valued at $13.9k
Disposed/sold 1,500 options to buy @ $11.35, valued at $17k
Disposed/sold 1,375 options to buy @ $20.6, valued at $28.3k
Disposed/sold 8,375 options to buy @ $23, valued at $192.6k
Disposed/sold 1,000 options to buy @ $23.95, valued at $24k
Disposed/sold 5,001 options to buy @ $40.32, valued at $201.6k
Disposed/sold 3,750 options to buy @ $40.74, valued at $152.8k
Disposed/sold 7,500 options to buy @ $80.35, valued at $602.6k
06/23/2015 4 TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 Bazemore Robert B (COO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 35,000 shares @ $0
Disposed/sold 50,000 options to buy @ $63.11, valued at $3.2M
06/23/2015 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 Williams Glen (SVP, Technical Operations) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 Malley Thomas (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/23/2015 4 WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/22/2015 4 BAKER JULIAN (10% Owner) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/22/2015 4 BAKER FELIX (10% Owner) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed of 206,800 shares @ $0
Acquired 19,318 shares @ $0
Disposed of 165,213 shares @ $0
Acquired 12,500 shares @ $0
Disposed of 55,479 shares @ $0
Acquired 5,543 shares @ $0
Disposed of 1,068,128 shares @ $0
Acquired 40,449 shares @ $0
Disposed of 100,490 shares @ $0
Acquired 497 shares @ $0
Disposed of 211,614 shares @ $0
06/09/2015 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/09/2015 4 Heberlig Chris (SVP, Finance & Business Ops.) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/09/2015 4 Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 72,000 shares @ $0
06/09/2015 4 Bazemore Robert B (COO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 5,000 shares @ $0
06/09/2015 4 Williams Glen (SVP, Technical Operations) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/09/2015 4 Quinn Anthony (EVP, CMO, & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
05/08/2015 4 Williams Glen (SVP, Technical Operations) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
04/29/2015 4 Quinn Anthony (EVP, CMO & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
04/23/2015 4 Quinn Anthony (EVP, CMO & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
04/17/2015 4 Quinn Anthony (EVP, CMO & Head of R&D) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
12/04/2013 4 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
11/04/2013 4 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
10/03/2013 4 Goldberg Mark Alan (SVP,Medical&Regulatory Affairs) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
08/20/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/29/2013 4 Patel Sanj K (President & CEO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
07/17/2013 4 Heberlig Chris (Vice President, Finance) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
07/15/2013 4 BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/10/2013 4 Williams Glen (SVP, Technical Operations) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
06/10/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy